Findings could inform novel treatments for the flu in humans.

If respiratory diseases were not complicated enough before COVID-19, this fall may be the example of peak complexity as atypical infectious disease seasons threaten to become ...

Down-regulating TAO2 prevents influenza from replicating in cells and could provide new target for antiviral therapies.

Researchers have shown for the first time that heart problems associated with the flu are not caused by raging inflammation in the lungs, as has long been predicted, according...

Acute respiratory tract infections (RTIs) have a high burden of disease and can be caused by a variety of pathogens that include viral and bacterial agents.1 The clinical presentation...

The Walgreens Flu Index shows that overall flu activity is 23% higher nationwide so far in the current season, compared to the 2020-2021 flu season. “The Walgreens Flu Index ...

Novavax said it has enrolled the first participants in a Phase 1/2 study to evaluate the safety and immunogenicity of a combination vaccine using the company's seasonal influenza...

The 2021-22 influenza season is likely to be more severe than average — and hit young children particularly hard — due to waning population-level immunity from the near-lack ...

Lead exposure in childhood may lead to less mature and less healthy personalities in adulthood, according to a new study led by psychology researchers at The University of Texas...

Moderna said the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the company’s quadrivalent seasonal influenza mRNA vaccine candidate. This Phase 1/2 ...